Evaluation The Effect of NB-UVB and Methotrexate on The Level of Serum Gelsolin in Psoriatic Patients
Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Psoriasis is a common chronic, immune-mediated, skin disease with a significantly negative impact on patients' quality of life. It is one of papulosquamous diseases defined by erythematous plaques with silvery scales. The interplay among cytokines released by dendritic, Th1, Th2, and Th17 cells leads to the clinical manifestations seen in psoriasis. Although discovering novel biomarkers for psoriasis is challenging step., it may play an essential role in diagnosis, severity assessment and prediction of treatment outcome and prognosis of the disease
Eligibility
Participation Requirements
Sex: All
Minimum Age: 15
Maximum Age: 65
Healthy Volunteers: t
View:
• Patients with moderate to severe plaque psoriasis.
• No restriction of age, race nor occupation.
Locations
Other Locations
Egypt
Aswan University Hospital
RECRUITING
Aswān
Contact Information
Primary
Nourhan Salah Mohamed, Resident
dr.nourhan505@gmail.com
+201124152433
Backup
Mahmoud Ahmed Ali, Lecturer
dr.mahmoudali@aswu.edu.eg
+201002364902
Time Frame
Start Date: 2024-06-10
Estimated Completion Date: 2025-06-10
Participants
Target number of participants: 48
Treatments
Active_comparator: Group A: (Narrow Band Ultraviolet B)
About 12 patients will expose to 24 sessions of Narrow Band Ultraviolet B (NB-UVB) radiation (initial dose of 130 - 400 mJ / cm2 ) selected according to skin for 3 month.
Active_comparator: Group B: (Methotrexate )
About 12 patients will receive Methotrexate tablets (MTX) in dose of (0.3 mg/kg/week) along with folic acid (5 mg/day) for 3 month.
Active_comparator: Group C: (Methotrexate and Narrow Band Ultraviolet B)
About 12 patients will undergo the treatment by both Methotrexate tablets (MTX) and Narrow Band Ultraviolet B( NB-UVB) radiation.for 3 month.
Active_comparator: Group D (Control Group)
About 12 patients apparently healthy individuals as control group.and will not take any medication
Related Therapeutic Areas
Sponsors
Leads: Aswan University